Locations
Menlo Park, CA, USA
industry
Biotech · Biotechnology · Biotechnology Research · Drug Discovery · Healthcare · Health Care · HealthTech · Life Science · Medical · Pharmaceuticals · Science and Engineering · Therapeutics
Size
51 - 200 employees
Stage
Other
founded in
2018
Synthekine is an engineered cytokine therapeutics company that creates selective immunotherapies to improve cancer and inflammatory disease treatment paradigms. Using knowledge of cytokine structure and function, the company develops therapeutics that maximize cytokine efficacy while avoiding toxic side effects. Synthekine is developing a broad and deep pipeline of product candidates by leveraging principles of cytokine partial agonism and immunological specificity across multiple protein engineering platforms. Modified cytokines, cytokine-enhanced cell therapies, and surrogate cytokine agonists are among the novel immunotherapies.
Something looks off?On-site & Remote